7.50% CONVERTIBLE SENIOR SECURED NOTES DUE 2019 INDENTURE between SUPERNUS PHARMACEUTICALS, INC., as Issuer and U.S. BANK NATIONAL ASSOCIATION, as Trustee and Collateral Agent Dated as of May 3, 2013Indenture • May 9th, 2013 • Supernus Pharmaceuticals Inc • Pharmaceutical preparations • New York
INDENTURE dated as of May 3, 2013 between SUPERNUS PHARMACEUTICALS, INC., a Delaware corporation, as issuer (“Company”), and U.S. BANK NATIONAL ASSOCIATION, as trustee (“Trustee”) and collateral agent (“Collateral Agent”).
SECURITY AND PLEDGE AGREEMENT Dated as of May 3, 2013 among Each Grantor From Time to time Party Hereto and U.S. BANK NATIONAL ASSOCIATION as Collateral Agent for the Secured Parties 7.50% Convertible Senior Secured Notes due 2019Security and Pledge Agreement • May 9th, 2013 • Supernus Pharmaceuticals Inc • Pharmaceutical preparations • New York
This SECURITY AND PLEDGE AGREEMENT (this “Agreement”), is entered into as of May 3, 2013, by and among the Grantors listed on the signature pages hereof and those additional Persons that hereafter become parties hereto by executing a Joinder (as defined below) (each, a “Grantor”, and collectively, the “Grantors”), and U.S. BANK NATIONAL ASSOCIATION as collateral agent for the Secured Parties (as defined below) (in such capacity, together with its successors and assigns in such capacity, “Collateral Agent”).
